No, prescribing labs for research study candidates are NOT considered non-clinical safety (NCS) specimens
Laboratory tests performed on human research participants are clinical specimens, not non-clinical safety specimens. The term "non-clinical" specifically refers to pre-human testing conducted in laboratory settings (in vitro) and animal models (in vivo) before any human exposure occurs 1.
Understanding the Terminology
Non-Clinical Studies Definition
Non-clinical studies encompass:
- Pharmacology studies (primary, secondary, and safety pharmacology)
- Pharmacokinetic/ADME studies in animal species
- Toxicology studies in relevant animal models
- Genotoxicity testing
- Carcinogenicity assessments (when warranted)
These studies must be completed BEFORE first-in-human (FIH) clinical trials can begin 1. The entire purpose of non-clinical testing is to ensure the drug candidate is safe enough to proceed to studies with human subjects 1.
Clinical vs. Non-Clinical Distinction
Once you are screening or enrolling human participants—even healthy volunteers in Phase 1 trials—you have entered the clinical phase of drug development. Laboratory tests drawn from these individuals are clinical specimens, regardless of whether the person ultimately enrolls in the study 2.
What "NCS" Likely Means in Your Context
The abbreviation "NCS" in the context of prescribing labs for research participants almost certainly refers to "Not Clinically Significant" rather than "non-clinical safety" 2. This is a completely different concept:
- NCS values are laboratory results that fall outside normal reference ranges but are deemed acceptable for study enrollment
- These represent temporary or minor deviations that don't pose safety concerns (e.g., slightly elevated liver enzymes after recent alcohol consumption, or mild variations in healthy volunteers who engage in heavy exercise) 2
- The determination of what constitutes NCS varies between studies and institutions, which can lead to inconsistent screening practices 2
Critical Pitfall to Avoid
Do not confuse non-clinical safety studies (animal/lab testing before human trials) with clinical laboratory safety monitoring (blood tests on human participants). These are entirely separate regulatory and scientific domains. Non-clinical studies are governed by ICH guidelines M3(R2), S6, S7A/B, and S9, while clinical laboratory testing follows Good Clinical Laboratory Practice (GCLP) standards 1, 3.
The prescribing labs you're referring to are part of the clinical trial screening process and should be managed according to clinical laboratory standards, not non-clinical safety study protocols.